Summary
Every year thousands of new drugs are developed and must undergo preclinical safety studies before clinical trials in man. Significantly, 1 in 4 compounds fail during this important evaluation stage, preventing significant side effects and adverse events in patients. These...
More information & hyperlinks
Web resources: | http://www.patholytix.com |